Executive VP & President of Merck Research Laboratories, Merck
Verified interview transcripts, podcast appearances, and direct quotes from Dean Li, Executive VP & President of Merck Research Laboratories at Merck. AI-verified speaker identity with full-text searchable transcripts.
Stephane Bancel, Moderna CEO, and Dr. Dean Li, Merck Research Laboratories president, join 'Squawk Box' to discuss details of an experimental personalized cancer vaccine that showed positive initial results in its first-ever late-stage trial, how the mRNA-based shot in combination with Merck’s immunotherapy Keytruda could serve as a new treatment option for melanoma, and more.
A panel featuring leaders across investment, tech, and industry discussed the "Era of TechBio" at Recursion's event at the San Francisco Mint during the 2025 J.P. Morgan Healthcare Conference. In a panel discussion led by Natasha Loder of The Economist, panelists answered the question – when it comes to TechBio, are we there yet? Dean Li, executive vice president and president of Merck Research Laboratories, said the “era of computational power will effect every industry,” and that TechBio “flavor” will be embedded throughout the pharma industry. Kimberly Powell, vice president of heal…
Missed Utah Tech Week's Biotech Breakthroughs event? Don't worry! Catch the insightful panel discussion featuring Dean Li, EVP & President of Merck Research Laboratories, and Chris Gibson, Co-Founder & CEO of Recursion, as they share their journey from academia to entrepreneurship. Learn about Recursion's pioneering work in decoding biology and industrializing drug discovery. Stay tuned for exciting announcements, including the Chris and Summer Gibson Founder's Fellowship, aimed at nurturing the next generation of biotech innovators. Watch the recording now for invaluable insights and inspirat…
Dean Li, MD, PhD, Co-founder and Board member at Recursion and President of Merck Research Labs, presents an afternoon convocation at Recursion's Download Day 2023. About Recursion: Recursion is a clinical-stage biotechnology company that aims to decode biology to radically improve lives. Recursion is harnessing the convergence of multiple breakthrough technologies that allow scientists to explore uncharted areas of biology and unravel its complexity to navigate the path to better treatments. The company has built a massive proprietary biological and chemical database that predicts trillion…
Dean Li, MD, PhD, president of Merck Research Laboratories, took center stage in a fireside chat with Recursion CEO and BioHive Co-Founder, Chris Gibson, for a riveting conversation about Utah’s innovation landscape, the future of healthcare research and Merck’s efforts in battling COVID-19 at the 2021 Virtual BioHive Summit.
Sign in to search the full transcript archive, filter by topic, and access every quote from Dean Li.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans